AMT-116 in Patients With Advanced Solid Tumors

Clinical trial NCT05725291 · RECRUITING

Trial details

NCT number: NCT05725291
Sponsor: Multitude Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-07-25
Primary completion: 2026-12-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.